RT Journal Article
SR Electronic
T1 Modelling Singapore COVID-19 pandemic with a SEIR multiplex network model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.31.20118372
DO 10.1101/2020.05.31.20118372
A1 N. N. Chung
A1 L. Y. Chew
YR 2020
UL http://medrxiv.org/content/early/2020/06/03/2020.05.31.20118372.abstract
AB In this paper, we have implemented a large-scale agent-based model to study the outbreak of coronavirus infectious diseases (COVID-19) in Singapore, taking into account complex human interaction pattern. In particular, the concept of multiplex network is utilized to differentiate between social interactions that happen in households and workplaces. In addition, weak interactions among crowds, transient interactions within social gatherings, and dense human contact between foreign workers in dormitories are also taken into consideration. Such a categorization in terms of a multiplex of social network connections together with the Susceptible-Exposed-Infectious-Removed (SEIR) epidemic model have enabled a more precise study of the feasibility and efficacy of control measures such as social distancing, work from home, and lockdown, at different moments and stages of the pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is not supported by any funding sourceAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NIL. We are using secondary data which does not involve human subjectAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available at Singapore Ministry of Health webpage - https://www.moh.gov.sg/covid-19